Werewolf Therapeutics (HOWL) Stock Chart & Stock Price History $1.19 +0.01 (+0.85%) As of 12:28 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Werewolf Therapeutics Stock Price Performance The Werewolf Therapeutics (HOWL) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 35.68%, with a year-to-date return of -19.59%. In the past month, the stock has increased 12.26%, reflecting recent market activity. As of the latest close, Werewolf Therapeutics traded at $1.18 with a market cap of $52.95 million and volume of 65,298 shares. Receive HOWL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Werewolf Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+2.59%1 Month Performance+12.26%3 Month Performance+36.78%Year-To-Date Performance-19.59%1 Year Performance-35.68% HOWL Stock Chart for Friday, August, 8, 2025 HOWL Chart by TradingView Werewolf Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/07/2025$1.19$1.18-0.84%$1.21$1.1765,298 shs$52.95 million08/06/2025$1.21$1.19-1.65%$1.24$1.19103,932 shs$53.40 million08/05/2025$1.24$1.21-2.42%$1.29$1.2166,020 shs$54.29 million08/04/2025$1.16$1.24+6.90%$1.26$1.1797,193 shs$55.64 million08/01/2025$1.21$1.16-4.13%$1.22$1.15182,679 shs$52.05 million07/31/2025$1.20$1.21+0.83%$1.28$1.20152,986 shs$54.29 million07/30/2025$1.30$1.20-7.69%$1.34$1.20356,593 shs$53.84 million07/29/2025$1.35$1.30-3.70%$1.35$1.30216,192 shs$58.34 million07/28/2025$1.36$1.35-0.74%$1.43$1.31351,274 shs$60.58 million07/25/2025$1.37$1.36-0.73%$1.39$1.32124,688 shs$61.02 million Get the Latest News and Ratings for HOWL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Werewolf Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/24/2025$1.39$1.37-1.44%$1.43$1.25338,714 shs$61.47 million07/23/2025$1.40$1.39-0.71%$1.44$1.39242,364 shs$62.38 million07/22/2025$1.40$1.40$1.43$1.33198,028 shs$62.82 million07/21/2025$1.41$1.40-0.71%$1.49$1.36400,746 shs$62.82 million07/18/2025$1.40$1.41+0.71%$1.44$1.35402,513 shs$63.27 million07/17/2025$1.35$1.40+3.70%$1.50$1.35616,973 shs$62.82 million07/16/2025$1.31$1.35+3.05%$1.37$1.25341,656 shs$60.58 million07/15/2025$1.29$1.31+1.55%$1.39$1.26391,034 shs$58.79 million07/14/2025$1.19$1.29+8.40%$1.30$1.20465,122 shs$57.89 million07/11/2025$1.08$1.19+10.19%$1.25$1.07705,751 shs$53.40 million07/10/2025$1.07$1.08+0.93%$1.09$1.06544,877 shs$48.46 million07/09/2025$1.06$1.07+0.94%$1.10$1.05407,170 shs$48.01 million07/08/2025$1.05$1.06+0.95%$1.08$1.05364,324 shs$47.56 million07/07/2025$1.08$1.05-2.87%$1.08$1.03240,132 shs$48.02 million Related Companies AC Immune Stock Price Chart Replimune Group Stock Price Chart SOPHiA GENETICS Stock Price Chart Aerovate Therapeutics Stock Price Chart Adherex Technologies Stock Price Chart biote Stock Price Chart ProQR Therapeutics Stock Price Chart Canopy Growth Stock Price Chart Design Therapeutics Stock Price Chart Liminatus Pharma Stock Price Chart Receive HOWL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Werewolf Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:HOWL) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersGreen Light for These StocksGuess Who Washington Will Partner With Next? The U.S. government just made a bold $400 million move... beco...Stansberry Research | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | SponsoredThe Day Silicon DiesThe Day China Left America's Supercomputers in the Dust In 200 seconds, China's quantum computer accomplish...The Oxford Club | SponsoredThis accelerated income plan is solving American's #1 retirement fearThe #1 fear in retirement today? Running out of money. That’s why income expert Tim Plaehn created a simple...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Werewolf Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Werewolf Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
